Package 67751-119-01

Brand: excedrin extra strength pain reliever

Generic: acetaminophen, aspirin (nsaid), and caffeine
NDC Package

Package Facts

Identity

Package NDC 67751-119-01
Digits Only 6775111901
Product NDC 67751-119
Description

1 POUCH in 1 CARTON (67751-119-01) / 2 TABLET, FILM COATED in 1 POUCH

Marketing

Marketing Status
Marketed Since 2019-03-15
Brand excedrin extra strength pain reliever
Generic acetaminophen, aspirin (nsaid), and caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "239668fa-359b-fe6e-e063-6394a90a98af", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["f7e572e9-82a7-2127-e053-6394a90ab01a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (67751-119-01)  / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-01", "marketing_start_date": "20190315"}, {"sample": false, "description": "2 POUCH in 1 CARTON (67751-119-02)  / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "67751-119-02", "marketing_start_date": "20190315"}], "brand_name": "Excedrin Extra Strength Pain Reliever", "product_id": "67751-119_239668fa-359b-fe6e-e063-6394a90a98af", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "67751-119", "generic_name": "Acetaminophen, Aspirin (NSAID), and Caffeine", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Excedrin", "brand_name_suffix": "Extra Strength Pain Reliever", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190315", "listing_expiration_date": "20261231"}